Sign Out
Do not use if particulates and/or discoloration are observed.
The solution can be allowed to come to room temperature prior to administration.
Octreotide is not compatible in Total Parenteral Nutrition (TPN) solutions because of the formation of a glycosyl octreotide conjugate which may decrease the efficacy of the product.
In case where Octreotide administered by i.v. infusion the content of 0.5 mg should normally be dissolved in 60 ml physiological saline (0.9% Normal saline) and the resulting solution should be infused by an infusion pump. This should be repeated as often as necessary until the prescribed duration of treatment is reached.
